Company Profile

Rebel Medicine Inc (AKA: 109 Therapeutics Inc)
Profile last edited on: 12/14/22      CAGE: 85SB9      UEI: T9CLT4WGBNP5

Business Identifier: Pain therapeutics
Year Founded
2018
First Award
2020
Latest Award
2022
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

630 Komas Drive Suite 300
Salt Lake City, UT 84108
   (754) 244-8906
   info@rebelmedicine.com
   www.rebelmedicine.com
Location: Single
Congr. District: 02
County: Salt Lake

Public Profile

Rebel is a preclinical-stage life sciences company addressing the task of developing innovative solutions to achieve opioid-free pain management. From the premise that acute pain is at this point in time primarily managed with opioids. management of Rebel Medicine Inc are addresings the issue of pain management locally - at the source - thereby eliminating the need for opioids and their side effects.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Key People / Management

  Brett Davis -- Co-Founder and CEO

  Jay Agarwal -- CMO

  Mike Beeman -- Senior Scientist

  Sierra Erickson -- Senior Engineer

  Pouya Hadipour -- Director of research & development

  Caleb Lade -- Co-Founder, COO

  Reid Neal -- Business Development Operations Manager

  Stefan Niederauer -- Director of Engineering

  Andrew Simpson

  Susan Wojtalewicz -- Senior engineer & co-founder

Company News

There are no news available.